Exact Mass: 249.1165
Exact Mass Matches: 249.1165
Found 500 metabolites which its exact mass value is equals to given mass value 249.1165,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
S-Acetyldihydrolipoamide
S-Acetyldihydrolipoamide is a thio-acetylated form of dihydrolipoamide. The molecule is commonly conjugated to lysine residues. The structure shown is the free form of the molecule. Pyruvate dehydrogenase complex. The reaction is 2-(alpha-hydroxyethyl)-TPP + lipoamide => S-acetyldihydrolipoamide + TPP [Homo sapiens], occuring in mitochondrial matrix. (reactome.org). S-Acetyldihydrolipoamide is an intermediate in alanine, aspartate and pyruvate metabolism and glycolysis/gluconeogenesis (KEGG:C01136). It is converted from 2-hydroxyethyl-THPP and lipoamide via the enzyme pyruvate dehydrogenase (EC:1.2.4.1). It is then converted to acetyl-CoA via the enzyme pyruvate dehydrogenase E2 component (dihydrolipoamide acetyltransferase) (EC:2.3.1.12). S-Acetyldihydrolipoamide is a thio-acetylated form of dihydrolipoamide. The molecule is commonly conjugated to lysine residues. The structure shown is the free form of the molecule.
Oxibendazole
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
Lansiumamide A
Lansiumamide A is found in fruits. Lansiumamide A is isolated from seeds of Clausena lansium (wampee). Isolated from seeds of Clausena lansium (wampee). Lansiumamide A is found in fruits.
Lysylcysteine
Lysylcysteine is a dipeptide composed of lysine and cysteine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Cysteinyl-Lysine
Cysteinyl-Lysine is a dipeptide composed of cysteine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
S-Acetyldihydrolipoamide-E
The acetyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue acetyltransferase (EC2.3.1.12). S-Acetyldihydrolipoamide-E is a reactant or product of enzyme EC 1.2.4.1. S-Acetyldihydrolipoamide-E is a reactant or product of enzyme EC 2.3.1.12. (PubChem sid=47205563) [HMDB] The acetyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue acetyltransferase (EC2.3.1.12). S-Acetyldihydrolipoamide-E is a reactant or product of enzyme EC 1.2.4.1. S-Acetyldihydrolipoamide-E is a reactant or product of enzyme EC 2.3.1.12. (PubChem sid=47205563).
Epinastine
Epinastine is used for the prevention of itching associated with allergic conjunctivitis. It has a multi-action effect that inhibits the allergic response in 3 ways: 1. stabilizes mast cells by preventing mast cell degranulation to control the allergic response, 2. prevents histamine binding to both the H1- and H2-receptors to stop itching and provide lasting protection, and 3. prevents the release of proinflammatory chemical mediators from the blood vessel to halt progression of the allergic response. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Epinastine (WAL801) is an antihistamine and mast cell stabilizer. Epinastine is a potent, selective and orally-active histamine H1 receptor antagonist. Epinastine also inhibits IL-8 release and has an antiallergic action[1][2][3][4].
Melatonin radical
This compound belongs to the family of Indolines. These are compounds containing an indole moiety, which consists of pyrrolidine ring fused to benzene to form 2,3-dihydroindole.
2-Pentanamido-3-phenylpropanoic acid
2-pentanamido-3-phenylpropanoic acid is classified as a phenylalanine or a Phenylalanine derivative. Phenylalanines are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 2-pentanamido-3-phenylpropanoic acid is considered to be a practically insoluble (in water) and a weak acidic compound. 2-pentanamido-3-phenylpropanoic acid can be found in feces.
(1Z)-1-(3-Ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one
(4Ar,10bR)-rel-4-Propyl-2,3,4,4a,5,10b-hexahydrochromeno[4,3-b][1,4]oxazin-9-ol
2',3'-Didehydro-2',3'-dideoxyguanosine
Benzo(f)quinolin-3(2H)-one, 8-chloro-1,4,4a,5,6,10b-hexahydro-4-methyl-, trans-
Acetophenone, 4'-hydroxy-3'-methoxy-2-(2-piperidyl)-
Amidantel
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
(S)-(4-Hydroxy-phenyl)-(S)-piperidin-2-yl-acetic acid methyl ester; hydrochloride
Oxibendazole
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
hexahomomethionine S-oxide
A sulfur-containing amino acid that is the sulfoxide obtained by formal oxygenation of the sulfur atom of hexahomomethionine.
Me glycoside,N-Ac-alpha-D-Pyranose-4-Amino-4-deoxyglucuronic acid
(+/-)-2-hydroxy-1-methyl-trans-zeatin|2-hydroxy-1-methylzeatin|2-hydroy-1-methylzeatin
N-[2-ethoxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
(1R)-5c-methoxy-(1rN,5rC2,8at)-6,7,8,8a-tetrahydro-1H-spiro[cyclohex-3-ene-1,5-pyrano[4,3-c]pyridin]-3-one
N-hydroxyhexahomomethionine
An N-hydroxy-alpha-amino acid having a 9-thiadecyl substituent at the 2-position.
2-amino-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]propanoic acid
(2E,4E)-N-(2-methylpropyl)-6-thiophen-2-ylhexa-2,4-dienamide
(2E,4E)-N-(2-methylpropyl)-6-thiophen-2-ylhexa-2,4-dienamide
Triallyl cyanurate
CONFIDENCE standard compound; INTERNAL_ID 407; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9255; ORIGINAL_PRECURSOR_SCAN_NO 9253 CONFIDENCE standard compound; INTERNAL_ID 407; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9282; ORIGINAL_PRECURSOR_SCAN_NO 9280 CONFIDENCE standard compound; INTERNAL_ID 407; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9293; ORIGINAL_PRECURSOR_SCAN_NO 9291 CONFIDENCE standard compound; INTERNAL_ID 407; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9319; ORIGINAL_PRECURSOR_SCAN_NO 9316 CONFIDENCE standard compound; INTERNAL_ID 407; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9326; ORIGINAL_PRECURSOR_SCAN_NO 9324
S-Acetyldihydrolipoamide-E
Epinastine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Epinastine (WAL801) is an antihistamine and mast cell stabilizer. Epinastine is a potent, selective and orally-active histamine H1 receptor antagonist. Epinastine also inhibits IL-8 release and has an antiallergic action[1][2][3][4].
(3-Amino-benzo[d]isoxazol-4-yl)-carbamic acid tert-butyl ester
2,5-Dimethoxy-4-(trifluoromethyl)phenethylamine
(S)-2-(Benzyloxycarbonylamino)-3-butenoic acid methyl ester
Butanoic acid, 3-oxo-,2-[methyl(phenylmethyl)amino]ethyl ester
(2S)-2-[(1,1-dioxothiolan-3-yl)amino]-4-methylpentanoic acid
1-(4-METHOXY-PHENYLAMINO)-CYCLOHEXANECARBOXYLIC ACID
tert-Butyl (5-aminobenzo[d]isoxazol-3-yl)carbamate
(R)-4-benzyl-5-oxomorpholine-3-carboxylic acid methyl ester
4-[4-(TERT-BUTYL)PHENYL]-5-MERCAPTO-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE
1-[3-methoxy-4-(morpholin-4-ylmethyl)phenyl]ethanone
4-Hydroxy-4-methylpiperidine-1-carboxylic acid benzyl ester
1-CHLORO-3-(1,3,3-TRIMETHYL-1,3-DIHYDRO-INDOL-2-YLIDENE)-PROPAN-2-ONE
2,6-DIFLUORO-4-(TRANS-4-ETHYLCYCLOHEXYL)-BENZONITRILE
Benzoic acid,4-[(1,3-dioxobutyl)amino]-, ethyl ester
(S)-(-)-1-(2-METHOXYBENZOYL)-2-(METHOXYMETHYL)PYRROLIDINE
Ethyl 3,7-dimethyl-4H-benzo[1,4]thiazine-2-carboxylate
Bay H 2049
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor
Phenol,2-[[(phenylmethyl)amino]methyl]-, hydrochloride (1:1)
1-[2-AMINO-1-(2-AMINO-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
1-[2-AMINO-1-(4-AMINO-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
3-HYDROXY-3-PHENYLAZETIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
(2S,3R)-2-Methyl-5-oxo-4-(phenylmethyl)-3-Morpholinecarboxylic acid
(1-thieno[3,2-d]pyrimidin-4-ylpiperidin-4-yl)methanol
[1-(1,3-Benzodioxol-5-ylmethyl)-4-piperidinyl]methanol
1-PHENYL-3-PYRIDIN-3-YL-1H-PYRAZOLE-4-CARBALDEHYDE
6-amino-6-methylcyclohexa-1,3-dien-1-ol,formaldehyde,phenol
(4-methoxyphenyl)(phenyl)methanamine hydrochloride
ethyl 1-(6-methylpyrazin-2-yl)piperidine-3-carboxylate
1-(2-ethoxyphenyl)-5-oxopyrrolidine-3-carboxylic acid
(6-(4-ACETYLPIPERAZIN-1-YL)PYRIDIN-3-YL)BORONIC ACID
ETHYL5-AMINO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
2-Oxazolidinone, 5-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl)-, (5R)-
ETHYL 5-ISOPROPYL-4-OXO-3,4-DIHYDROPYRROLO[2,1-F][1,2,4]TRIAZINE-6-CARBOXYLATE
tert-Butyl 6-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate
ethyl 5-amino-1-(4-fluorophenyl)pyrazole-4-carboxylate
(S)-2-METHYLPIPERIDINE (2R,3R)-2,3-DIHYDROXYSUCCINATE
(2-oxo-2-p-tolyl-ethyl)-carbamic acid tert-butyl ester
1-[2-AMINO-1-(3-AMINO-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
(4-(((TETRAHYDROFURAN-2-YL)METHYL)CARBAMOYL)PHENYL)BORONIC ACID
1-(tetrahydro-2H-pyran-4-yl)-4-piperidinecarboxylic acid(SALTDATA: HCl)
1-(tetrahydro-2H-pyran-4-yl)-3-piperidinecarboxylic acid(SALTDATA: HCl)
9,10-DIHYDRO-4H-BENZO(4,5)CYCLOHEPTA(1,2-B)THIOPHEN-4-ONE
4-Hydrazino-piperidine-1-carboxylic acid benzyl ester
PIPERIDINE-3-CARBOXYLIC ACID (4-NITRO-PHENYL)-AMIDE
PIPERIDINE-4-CARBOXYLIC ACID (4-NITRO-PHENYL)-AMIDE
PIPERIDINE-4-CARBOXYLIC ACID (2-NITRO-PHENYL)-AMIDE
3-Piperidinecarboxylic acid, 4-hydroxy-1-(phenylmethyl)-, methyl ester
Benzeneacetonitrile,3,4,5-trimethoxy-a-(1-methylethyl)-
tert-butyl3-amino-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate
(S)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid
tert-butyl 4-(furan-3-yl)-3,6-dihydro-2H-pyridine-1-carboxylate
[4-(4-methylphenoxy)phenyl]methanamine,hydrochloride
ETHYL5-AMINO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
(+)-ethyl (s)-2-amino-4-cyclohexylbutyrate hydrochloride
3-DIMETHOXYMETHYL-5-TRIMETHYLSILANYLETHYNYL-PYRIDINE
tert-Butyl 1-methyl-2-oxo-1H-imidazo[4,5-b]pyridine-3(2H)-carboxylate
4,4,5,5-Tetramethyl-2-(4-nitrophenyl)-1,3,2-dioxaborolane
1-Piperazineacetic acid, 4-(2-pyridinyl)-, ethyl ester
PIPERIDINE-3-CARBOXYLIC ACID (2-NITRO-PHENYL)-AMIDE
ETHYL5-AMINO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
2-AMINO-BENZOTHIAZOLE-6-CARBOXYLIC ACID SEC-BUTYLAMIDE
3-(3,3-dimethylbutanoylamino)-4-methylbenzoic acid
4-ethyl-3-[(2-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione
ethyl 1-(6-methylpyrazin-2-yl)piperidine-4-carboxylate
4-ETHYL-5-[(4-METHYLPHENOXY)METHYL]-4H-1,2,4-TRIAZOLE-3-THIOL
1-(2-Methoxybenzyl)-5-oxopyrrolidine-3-carboxylic acid
4-ethyl-3-(1-phenoxyethyl)-1H-1,2,4-triazole-5-thione
(R)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid
(2S,4R)-METHYL 1-BENZOYL-4-HYDROXYPYRROLIDINE-2-CARBOXYLATE
Pyrido[1,2-a]benzimidazole-4-carbonitrile, 3-methyl-1-(1-methylethyl)- (9CI)
1-(6-AMINO-5-METHOXYINDOLIN-1-YL)-2-(DIMETHYLAMINO)ETHANONE
tert-butyl N-[(4-formylphenyl)methyl]-N-methylcarbamate
4-(2-TRIFLUOROMETHYL-PHENOXY)-PIPERIDINEHYDROCHLORIDE
4-(2-methyl-6-propan-2-ylanilino)-4-oxobutanoic acid
1-(4-fluorophenyl)-1,3,8-triazaspiro[4,5]decan-4-one
ethyl 3,6,6-trimethyl-4-oxo-5,7-dihydro-1H-indole-2-carboxylate
tert-Butyl-[(2R)-1-oxo-3-phenylpropan-2-yl]carbamat
ethyl 2-(4-methylpiperazin-1-yl)pyridine-4-carboxylate
4,4,5,5-Tetramethyl-2-(3-nitrophenyl)-1,3,2-dioxaborolane
2-[bis(2-hydroxyethyl)amino]ethanol,oxolane-2,5-dione
tert-butyl 7-(hydroxymethyl)-2,3-dihydroindole-1-carboxylate
TERT-BUTYL 2-(HYDROXYMETHYL)-1-INDOLINECARBOXYLATE
1-PHENYL-3-PYRIDIN-4-YL-1H-PYRAZOLE-4-CARBALDEHYDE
4-propyl-3,4a,5,10b-tetrahydro-2H-chromeno[4,3-b][1,4]oxazin-9-ol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
4-(2-cyclopropyl-4-ethylpyrimidin-5-yl)benzonitrile
TERT-BUTYL (3-HYDROXY-2,3-DIHYDRO-1H-INDEN-1-YL)CARBAMATE
(S)-4,9-DIHYDRO-1-METHYL-3H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLICACID
1-(3-HYDROXYPHENYL)-1-METHOXY-1-(2-THIAZOLYL)-PROPANE
ethyl 6-(4-aminopiperidin-1-yl)pyridine-3-carboxylate
1-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazine
ethyl 4-acetyl-1-cyclopropyl-2,5-dimethylpyrrole-3-carboxylate
6-(benzo[d][1,3]dioxol-5-ylmethyl)-2-thia-6-azaspiro[3.3]heptane
(2S,5R)-5-(benzyloxyamino)-piperidine-2-carboxylic acid amide
(R)-Benzyloxycarbonylamino-cyclopropyl-acetic acid
(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-((S)-3-hydroxy-pyrrolidin-1-yl)-Methanone
(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-((R)-3-hydroxy-pyrrolidin-1-yl)-Methanone
[(1R,2R)-2-hydroxycyclohexyl]CarbaMic acidphenylMethyl ester
TERT-BUTYL 5-HYDROXY-3,4-DIHYDROQUINOLINE-1(2H)-CARBOXYLATE
TERT-BUTYL 7-HYDROXY-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE
2-Methyl-2-Propanyl 5-Hydroxy-3,4-Dihydro-2(1H)-Isoquinolinecarboxylate
METHYL 7-ALLYL-6-HYDROXY-5-OXO-1,2,3,5-TETRAHYDROINDOLIZINE-8-CARBOXYATE
1-[(4-METHYLPHENYL)METHYL]-1H-INDOLE-3-CARBALDEHYDE
1-(4-METHOXY-BENZYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID
3-(2-NITROPHENYL)-2-PROPENOIC ACID1,1-DIMETHYLETHYL ESTER
(4aR,7aR)-octahydro-6-(phenylmethyl)-1H-Pyrrolo[3,4-b]pyridine
6-Hydroxy-3,4-dihydro-2H-quinoline-1-carboxylic acid tert-butyl ester
3-(4-Diethylamino-2-hydroxy-phenyl)-2-methyl-propionic acid
bexlosteride
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent
5-Benzofuranol, 2,3-dihydro-3,3-dimethyl-2-(4-morpholinyl)-
7-Amino-2-methyl-3-phenylpyrazolo[1,5-a]pyrimidine-6-carbonitrile
N,N-dimethyl-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)thio]ethanamine
N-(4,5-dimethyl-1,3-benzothiazol-2-yl)propanehydrazide
(2E,4E)-N-Isobutyl-6-(2-thienyl)hexa-2,4-dienamide
(R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)benzyl)guanidine
2-Amino-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]propanoic acid
1-Deoxy-11beta-hydroxypentalenate
A hydroxy monocarboxylic acid anion that is the conjugate base of 1-deoxy-11beta-hydroxypentalenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
8beta-Hydroxygermacra-1(10),4,11(13)-trien-12-oate
6alpha-Hydroxygermacra-1(10),4,11(13)-trien-12-oate
8alpha-Hydroxygermacra-1(10),4,11(13)-trien-12-oate
(4S)-4-(5,5-dimethylcyclohex-1-en-1-yl)-4-hydroxycyclohex-1-ene-1-carboxylic acid
(2S)-2-azaniumyl-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}propanoate
(2R)-2-(Acetylamino)-3-(1,1-dimethyl-3-hydroxypropylthio)propionic acid
5-(4-Chlorophenyl)-6-ethylpyrimidin-3-ium-2,4-diamine
(1S,2R,5R,9R)-9-hydroxy-2,10,10-trimethyltricyclo[6.3.0.01,5]undec-6-ene-6-carboxylate
(2S)-2-(hydroxyamino)-10-(methylsulfanyl)decanoic acid
(2S,3S,4S,5R)-5-(hydroxymethyl)-2-(morpholin-4-ylmethyl)oxolane-2,3,4-triol
(1E)-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one
2-amino-9-[5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-1H-purin-6-one
N-(2,3-dihydro-1H-inden-1-yl)-N-prop-2-ynylmethanesulfonamide
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors D020011 - Protective Agents
N-[2-(4-hydroxyphenyl)-2-oxoethyl]hexanamide
A natural product found in Cystobacter ferrugineus.
N-[2-(4-hydroxyphenyl)-2-oxoethyl]-4-methylpentanamide
A natural product found in Cystobacter ferrugineus.
8,5-Cyclo-2-deoxyadenosine
An organic heterotetracyclic compound obtained by intramolecular formation of a C-C bond between positions 8 and 5 of 2-deoxyadenosine.
Pentalenate
A hydroxy monocarboxylic acid anion that is the conjugate base of pentalenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
2-(4,5-dihydro-1H-imidazol-2-ylthio)-N-(4-methylphenyl)acetamide
Propionylamino-acetic acid 2-oxo-2-phenyl-ethyl ester
N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-2,2-dimethylpropanamide
2-(5-Methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)-2-phenylacetonitrile
N-(3,4,5,6-tetrahydro-2H-azepin-7-yl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine
(3Z)-9-methyldec-3-en-1-yl sulfate
An organosulfate oxoanion that is the conjugate base of (3Z)-9-methyldec-3-en-1-yl hydrogen sulfate. It has been isolated from Daphnia pulex and has been shown to cause morphological changes in the green alga Scenedesmus gutwinskii.
(3S,4E)-3-methyldec-4-en-1-yl sulfate
An organosulfate oxoanion that is the conjugate base of (3S,4E)-3-methyldec-4-en-1-yl hydrogen sulfate. It has been isolated from Daphnia pulex and has been found to induce morphological changes in the phytoplankton, Scenedesmus gutwinskii.
(R)-S(6)-acetyldihydrolipoamide
The (R)-enantiomer of S(6)-acetyldihydrolipoamide.
[2-Chloroethyl-[(4-methylcyclohexyl)carbamoyl]amino]-oxidoazanium
5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid
6-[(Z)-hydroxyiminomethyl]-N-(oxolan-2-ylmethyl)pyridine-3-carboxamide
1-Benzyl-2,2,5,5-tetramethyl-2,5-disilapyrrolidine
ethyl N-acetyl-beta-D-glucosaminide
An N-acetyl-beta-D-glucosaminide having ethyl as the anomeric substituent.
ML351
ML351 is a potent and highly specific 15-LOX-1 inhibitor with an IC50 of 200 nM. ML351 shows excellent selectivity (>250-fold) versus the related isozymes, 5-LOX, platelet 12-LOX, 15-LOX-2, ovine COX-1, and human COX-2[1].?ML351 prevents dysglycemia and reduces β-cell oxidative stress in nonobese diabetic mouse model of T1D[2].
SY-LB-35
SY-LB-35 is a potent bone morphogenetic protein (BMP) receptor agonist. SY-LB-35 can stimulate significant increases in cell number and cell viability in the C2C12 myoblast cell line, and causes shifts towards the S and G2/M phases of the cell cycle. SY-LB-35 stimulates canonical Smad and non-canonical PI3K/Akt, ERK, p38 and JNK intracellular signaling pathways[1].
